photodynamic therapy

Type: Keyphrase
Name: photodynamic therapy
First reported 10 hours ago - Updated 8 hours ago - 1 reports

UT Arlington physicist creates new nanoparticle for cancer therapy

PUBLIC RELEASE DATE: 15-Apr-2014A University of Texas at Arlington physicist working to create a luminescent nanoparticle to use in security-related radiation detection may have instead happened upon an advance in photodynamic cancer therapy.Wei Chen, ... [Published EurekAlert! - 10 hours ago]
First reported 9 hours ago - Updated 9 hours ago - 1 reports

New Drug Delivery Systems Findings from Zhengzhou University Described

By a News Reporter-Staff News Editor at Biotech Week Researchers detail new data in Drugs and Therapies. According to news reporting originating in Zhengzhou, People's Republic of China, by NewsRx journalists, research stated, "Fullerene has shown great ... [Published Pharmacy Choice - 9 hours ago]
First reported 16 hours ago - Updated 16 hours ago - 1 reports

On the Record / April 16, 2014

Hires/Promotions/HonorsEmerging Business Leaders named Matthew Pelkey , of Colligan Law, chairman of its Advisory Board. Other officers: vice chairman, Rebecca Wantuck , Hearing Evaluation Services; event chair, Emily Ciraolo , National Fuel; marketing ... [Published Buffalo News - 16 hours ago]
First reported Apr 14 2014 - Updated Apr 15 2014 - 1 reports

A stable model for an unstable target

PUBLIC RELEASE DATE: 14-Apr-2014A study in The Journal of General Physiology provides new insights about singlet oxygen and sets the stage for better understanding of this highly reactive and challenging substance.Singlet oxygen is an electronically excited ... [Published EurekAlert! - Apr 14 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 1 reports

Unstable Singlet Oxygen: A Stable Model For An Unstable Target

Singlet oxygen is an electronically excited state of oxygen that is less stable than normal oxygen. Its high reactivity has enabled its use in photodynamic therapy, in which light is used in combination with a photosensitizing drug to generate large ... [Published Scientific Blogging - Apr 14 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 1 reports

New Drug Delivery Systems Findings from Zhengzhou University Described

By a News Reporter-Staff News Editor at Biotech Week -- Researchers detail new data in Drugs and Therapies. According to news reporting originating in Zhengzhou , People's Republic of China , by NewsRx journalists, research stated, "Fullerene has shown ... [Published HispanicBusiness.com - Apr 10 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

CT predicts photodynamic therapy treatment response

The study team from Dartmouth aimed to reduce the imaging obstacles for safe and minimally invasive PDT treatment. Their results revealed a connection between the amount of blood in a tumor and its response to the light-activated treatment.With photodynamic ... [Published Aunt Minnie - Apr 04 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 1 reports

Tetranuclear Gadolinium(III) Porphyrin Complex as a Theranostic Agent for Multimodal Imaging and Photodynamic Therapy

We describe herein the elaborate design of a Gd(III)–porphyrin complex as a theranostic agent for multimodal imaging and photodynamic therapy. Far-red-emitting (665 nm) and high relaxivity (14.1 mM–1 s–1) with 107% increase upon binding to HSA (human ... [Published Inorganic Chemistry - Apr 02 2014]
First reported Apr 02 2014 - Updated Apr 02 2014 - 2 reports

An Easier, Safer, and More Accurate Treatment for Pancreatic Cancer

Using CT scans with contrast enhancement, Dartmouth researchers measured treatment response to pancreatic cancer photodynamic therapy (PDT) according to a paper published in Physics in Medicine and Biology. ... [Published News at Dartmouth Medical School - Apr 02 2014]
First reported Apr 01 2014 - Updated Apr 02 2014 - 2 reports

RPCI receives FDA approval to enroll patients in phase II clinical trial of I-PDT to tumors of head and neck

Roswell Park Cancer Institute (RPCI) has received U.S. Food and Drug Administration (FDA) approval to enroll patients in a phase II clinical trial that will use a unique and highly precise method of delivering interstitial photodynamic therapy (I-PDT) ... [Published News-Medical.Net - Apr 02 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

Roswell Park Gets Green Light for Phase II Clinical Trial Using Interstitial Photodynamic Therapy

Roswell Park Cancer Institute investigators will assess the effectiveness of a novel interstitial photodynamic therapy (I-PDT) approach for treating recurrent head and neck cancers. ... [Published Infrosoft - Apr 01 2014]
First reported Mar 26 2014 - Updated Mar 27 2014 - 3 reports

FDA approves fiber-optic light delivery system for lung, esophageal cancer treatment

Pinnacle Biologics (Bannockburn, IL), a biopharmaceutical R&D company specializing in rare diseases, has received FDA premarket supplemental approval for its Optiguide DCYL700 Fiber Optic Diffuser Series flexible fiber—a light delivery system used in ... [Published OptoIQ - Mar 27 2014]

Quotes

According to the news reporters, the research concluded: "These results suggest that C60-PEI-DOX may be promising for high treatment efficacy with minimal side effects in future therapy."
"For cancer, there is still no good solution yet. Hopefully this nanoparticle can provide some possibilities" he said. About UT Arlington
...According to news reporting out of Stanford, California , by NewsRx editors, research stated, "Methylene blue-loaded gold nanorod@SiO2 (MB-GNR@SiO2) core@shell nanoparticles are synthesized for use in cancer imaging and photothermal/photodynamic dual therapy. For the preparation of GNR@SiO2 nanoparticles, we found that the silica coating rate of hexadecylcetyltrimethylammonium bromide (CTAB)-capped GNRs is much slower than that of PEGylated GNRs due to the densely coated CTAB bilayer."
"U SS Pat. No. 3,986,510 discusses ocular inserts having one or more inner reservoirs of a drug formulation confined within a bioerodible drug release rate controlling material of a shape adapted for insertion and retention in the 'sac of the eye,' which is indicated as being bounded by the surfaces of the bulbar conjunctiva of the sclera of the eyeball and the palpebral conjunctiva of the eyelid, or for placement over the corneal section of the eye."

More Content

All (122) | News (118) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (1) | Press Releases (0)
sort by: Date | Relevance
New Drug Delivery Systems Findings from Zhengzh... [Published Pharmacy Choice - 9 hours ago]
UT Arlington physicist creates new nanoparticle... [Published EurekAlert! - 10 hours ago]
On the Record / April 16, 2014 [Published Buffalo News - 16 hours ago]
Cytotoxic Effect of Protoporphyrin IX to Human ... [Published Sexual Development - Apr 16 2014]
Unstable Singlet Oxygen: A Stable Model For An ... [Published Scientific Blogging - Apr 14 2014]
A stable model for an unstable target [Published EurekAlert! - Apr 14 2014]
Findings from Stanford University Update Unders... [Published HispanicBusiness.com - Apr 10 2014]
New Drug Delivery Systems Findings from Zhengzh... [Published HispanicBusiness.com - Apr 10 2014]
ALLERGAN : Patent Issued for Extended Release B... [Published 4 Traders - Apr 10 2014]
Treatment of varicose veins ELVeS Radial™ espec... [Published Pressbox.co.uk - Apr 10 2014]
Patent Issued for Medical Apparatus Employing F... [Published 4 Traders - Apr 10 2014]
Navigating the Regulatory Landscape of Combinat... [Published PharmTech.com - Apr 08 2014]
Can genetic therapy solve the AMD puzzle? [Published Ophthalmology Management - Apr 08 2014]
3-D imaging: Easier, safer, more accurate treat... [Published Science Daily - Apr 07 2014]
4/7/14 - FDA Approves Optiguide® DCYL700 Fiber... [Published Pharmacy Choice - Apr 07 2014]
CT predicts photodynamic therapy treatment resp... [Published Aunt Minnie - Apr 04 2014]
Data from Singapore National University Provide... [Published NewsRX - Apr 04 2014]
Two Orders of Magnitude Fluorescence Enhanceme... [Published ACS Applied Materials & Interfaces - Apr 04 2014]
Dartmouth researchers studying new pancreatic c... [Published Union Leader - Apr 03 2014]
Dr. Sabrina Fabi of Cosmetic Laser Dermatology ... [Published PRWeb - Apr 03 2014]
Data from Singapore National University Provide... [Published HispanicBusiness.com - Apr 03 2014]
Patent Issued for Fullerene Compositions and Me... [Published HispanicBusiness.com - Apr 02 2014]
New Chalcogens Findings from University of Mich... [Published HispanicBusiness.com - Apr 02 2014]
Findings from Stanford University Update Unders... [Published HispanicBusiness.com - Apr 02 2014]
Tetranuclear Gadolinium(III) Porphyrin Complex... [Published Inorganic Chemistry - Apr 02 2014]
Patent Application Titled "Fluorescent Hybrid o... [Published 4 Traders - Apr 02 2014]
Research Conducted at Novartis Pharma Has Provi... [Published 4 Traders - Apr 02 2014]
An Easier, Safer, and More Accurate Treatment f... [Published News at Dartmouth Medical School - Apr 02 2014]
Laser Marketplace: Forging innovation: Laser Ma... [Published OptoIQ - Apr 02 2014]
An Easier, Safer, and More Accurate Treatment f... [Published Newswise - Apr 02 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Unstable Singlet Oxygen: A Stable Model For An ... [Published Scientific Blogging - Apr 14 2014]
Singlet oxygen is an electronically excited state of oxygen that is less stable than normal oxygen. Its high reactivity has enabled its use in photodynamic therapy, in which light is used in combination with a photosensitizing drug to generate large ...
An Easier, Safer, and More Accurate Treatment f... [Published News at Dartmouth Medical School - Apr 02 2014]
Using CT scans with contrast enhancement, Dartmouth researchers measured treatment response to pancreatic cancer photodynamic therapy (PDT) according to a paper published in Physics in Medicine and Biology. ...
Dr. George Tegos Joins Advisory Board at Peptin... [Published PR.com Press Releases - Jan 29 2014]
Albuquerque, NM, January 29, 2014 --( PR.com )-- Peptineo, a biotechnology company focused on value recovery in Pharma, announces the appointment of George Tegos, PhD, to the company's Scientific Advisory Board. "We are extremely pleased that Dr. Tegos ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.